Sarepta names Michael Severino CEO, succeeding retiring Doug Ingram - SRPT News | RalliesSarepta names Michael Severino CEO, succeeding retiring Doug Ingram
S
SRPT• Sarepta appoints new chief executive
- Sarepta appointed Michael Severino as CEO, effective July 28, 2026.
- Severino was previously CEO of Tessera Therapeutics.
- He earlier served as vice chairman and president at AbbVie, leading R&D and corporate strategy.
- Severino will join the board; Doug Ingram will retire and remain an adviser through the end of 2026.
•